CSIMarket
 
Karyopharm Therapeutics Inc   (NASDAQ: KPTI)
 

Karyopharm Therapeutics Inc's Customers Performance

KPTI



 
KPTI's Source of Revenues During the corresponding time, Karyopharm Therapeutics Inc saw a revenue deteriorated by -11.86 % year on year, sequentially revenue fell by -4.66 %. While revenue at the Karyopharm Therapeutics Inc 's corporate clients

List of KPTI Customers




for the same period Karyopharm Therapeutics Inc revnue deteriorated by -11.86 % year on year, sequentially revenue fell by -4.66 %.

List of KPTI Customers

Karyopharm Therapeutics Inc's Business Units
Product    179.29 % of total Revenue
License and Other    25.6 % of total Revenue
Member    204.89 % of total Revenue
Royalty    3.59 % of total Revenue
License and Service    8.08 % of total Revenue






Karyopharm Therapeutics Inc's Comment on Sales, Marketing and Customers
















KPTI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Karyopharm Therapeutics Inc 49.19 151.12 -194.97 228
SUBTOTAL 0.00 0.00 0.00 -

Sources: Karyopharm Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Karyopharm Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Karyopharm Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.